Skip to main content

Advertisement

SpringerLink
Log in

Assessment of metabolic risk factors for nephrolithiasis in patients with autosomal dominant polycystic kidney disease: a cross-sectional study

  • Original article
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

Abstract

Background

Nephrolithiasis is more common in autosomal dominant polycystic kidney disease (ADPKD) than in the normal population. We aimed to investigate the anatomical and metabolic factors that may be associated with nephrolithiasis in patients with ADPKD

Methods

In this cross-sectional study, a total of 180 participants were included. Eighty-five patients with ADPKD [42 patients with nephrolithiasis (PKD N +) and 43 without nephrolithiasis (PKD N –)] were recruited. Forty-seven nephrolithiasis patients without ADPKD (N) and 48 healthy controls (HC) were selected as control groups. 24-h urine collections were measured in all participants. 24-h urine citrate, calcium, urate, oxalate, magnesium and sodium, serum electrolytes, and eGFRs were compared.

Results

Total kidney volumes were not different between patients with PKD N + and PKD N –. Hypocitraturia was common in all patients with ADPKD (69.4%), and it was not different between PKD N + (76.2%) and PKD N- (62.8%). However, hypocitraturia was statistically higher in PKD N + and PKD N – than in N (38.3%) and HC (12.5%) (p<0.05). 24-h urine calcium, urate, and oxalate levels were similar between PKD N + and PKD N –

Conclusions

Hypocitraturia was found to be significantly higher in patients with ADPKD than in healthy adults and other kidney stone patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Torres VE, Harris PC. Autosomal dominant polycystic kidney disease. Nefrologia. 2003;23(Suppl 1):14–22.

    PubMed  Google Scholar 

  2. Torres VE, Harris PC. Autosomal dominant polycystic kidney disease: the last 3 years. Kidney Int. 2009;76(2):149–68.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Levine E, Grantham JJ. Calcified renal stones and cyst calcifications in autosomal dominant polycystic kidney disease: clinical and CT study in 84 patients. AJR Am J Roentgenol. 1992;159(1):77–81.

    Article  CAS  PubMed  Google Scholar 

  4. Torres VE, Erickson SB, Smith LH, Wilson DM, Hattery RR, Segura JW. The association of nephrolithiasis and autosomal dominant polycystic kidney disease. Am J Kidney Dis. 1988;11(4):318–25.

    Article  CAS  PubMed  Google Scholar 

  5. Amar AD, Das S, Egan RM. Management of urinary calculous disease in patients with renal cysts: review of 12 years of experience in 18 patients. J Urol. 1981;125(2):153–6.

    Article  CAS  PubMed  Google Scholar 

  6. Torres VE, Wilson DM, Hattery RR, Segura JW. Renal stone disease in autosomal dominant polycystic kidney disease. Am J Kidney Dis. 1993;22(4):513–9.

    Article  CAS  PubMed  Google Scholar 

  7. Grampsas SA, Chandhoke PS, Fan J, Glass MA, Townsend R, Johnson AM, Gabow P. Anatomic and metabolic risk factors for nephrolithiasis in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis. 2000;36(1):53–7.

    Article  CAS  PubMed  Google Scholar 

  8. Nishiura JL, Neves RF, Eloi SR, Cintra SM, Ajzen SA, Heilberg IP. Evaluation of nephrolithiasis in autosomal dominant polycystic kidney disease patients. Clin J Am Soc Nephrol. 2009;4(4):838–44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Chapman AB, Devuyst O, Eckardt KU, Gansevoort RT, Harris T, Horie S, Kasiske BL, Odland D, Pei Y, Perrone RD, Pirson Y, Schrier RW, Torra R, Torres VE, Watnick T, Wheeler DC, Conference Participants. Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int. 2015;88(1):17–27.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Keddis MT, Rule AD. Nephrolithiasis and loss of kidney function. Curr Opin Nephrol Hypertens. 2013;22(4):390–6.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Delaney VB, Adler S, Bruns FJ, Licinia M, Segel DP, Fraley DS. Autosomal dominant polycystic kidney disease: presentation, complications, and prognosis. Am J Kidney Dis. 1985;5(2):104–11.

    Article  CAS  PubMed  Google Scholar 

  13. Curhan GC. Epidemiology of stone disease. Urol Clin North Am. 2007;34(3):287–93.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Borrego Utiel FJ, Herrera Contreras I, Merino García E, Camacho Reina MV, Moriana Domínguez C, Ocaña PE. Urinary citrate as a marker of renal function in patients with autosomal dominant polycystic kidney disease. Int Urol Nephrol. 2022;54(4):873–81.

    Article  CAS  PubMed  Google Scholar 

  15. Goodarzi MT, Forouzanfar F, Moaddab AH, Karimian M, Sabzevar NK. Comparison of 24-hour urinary citrate excretion in stone formers and healthy volunteers. Saudi J Kidney Dis Transpl. 2012;23(6):1227–31.

    PubMed  Google Scholar 

  16. Riddle HAL, Zhang S, Qian F, Williams JC Jr, Stubbs JR, Rowe PSN, Parnell SC. Kidney stone formation in a novel murine model of polycystic kidney disease. Am J Physiol Renal Physiol. 2022;323(1):F59–68.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Ferraz RR, Fonseca JM, Germino GG, Onuchic LF, Heilberg IP. Determination of urinary lithogenic parameters in murine models orthologous to autosomal dominant polycystic kidney disease. Urolithiasis. 2014;42(4):301–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Leslie SW, Bashir K. Hypocitraturia And Renal Calculi. [Updated 2023 Jan 4]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK564392.

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Bezmialem Vakif University School of Medicine, Istanbul, Turkey

    Onour Chasan

  2. Division of Endocrinology, Department of Internal Medicine, Istanbul University Istanbul Faculty of Medicine, Istanbul, Turkey

    Onour Chasan

  3. Division of Nephrology, Department of Internal Medicine, Bezmialem Vakif University School of Medicine, Adnan Menderes Blv Fatih, 34093, Istanbul, Turkey

    Safak Mirioglu, Ayse Serra Artan, Meltem Gursu, Rumeyza Kazancioglu & Omer Celal Elcioglu

  4. Division of Nephrology, Department of Internal Medicine, Istanbul University Istanbul Faculty of Medicine, Istanbul, Turkey

    Ayse Serra Artan

Authors
  1. Onour Chasan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Safak Mirioglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ayse Serra Artan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Meltem Gursu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rumeyza Kazancioglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Omer Celal Elcioglu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Omer Celal Elcioglu.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chasan, O., Mirioglu, S., Artan, A.S. et al. Assessment of metabolic risk factors for nephrolithiasis in patients with autosomal dominant polycystic kidney disease: a cross-sectional study. Clin Exp Nephrol 27, 912–918 (2023). https://doi.org/10.1007/s10157-023-02378-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-023-02378-2

Keywords

Search

Navigation